Australia's largest stock trading and investment forum Australia's #1 stock forum

PAA

2.63%

19.5¢ pharmaust limited

Paradigm Shift, page-22

First 22 Last

Share
Profile

Follow
PickEm

927 Posts.

596

06/07/20

13:13

Post #: 45668707
Share

Originally posted by theoc: ↑

Again good points thanks PickEm. Laymans question for you if I may.
In veery basic term we now know that there is a "U" shaped effect re the job of MTor however the dog announcement made (seemed unplanned or even surprising) reference to dose levels delivered being more effective at lower dose than anticipated. On that basis how (still) blind do you think PAA scientists are operating ?
and supplementary question.
there is obvious differences between cancer and Covid but both effected by levels/ activity of MTor - I'm struggling with the basic differences. Can you help me join the dots of that one ? Is it the case that the treatment is not actually directly connected to the disease but more the regulation of the bodies ability to correct / control activity around it to prevent the opportunity to multiply - and therefore create the commonality between say cancer and Covid ? - if that makes any sense at all (obviously exposing and confirming my absolute lack of science here so please forgive)

Reason I am asking is, my initial understanding was that there was a substantial latitude in the effective dosing of Monepantel however, if this then orchestrates the needle along this "U' shaped mTor activity is dosing levels not a more precise requirement ?

Sorry that's 3 questions !

Expand

Hi theoc
Just a quick part reply as I'm pressed for time.

PharmAust are aware of Adaptive Cell Therapy and I'm confident it is in consideration going forward. I have faith that PharmAust will go wherever the data leads them - and man I'd love to know what that data suggests

PAA Price at posting: 23.5¢ Sentiment: Hold Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 19 more messages in this thread...

First 22 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 19.5¢		Change 0.005(2.63%)		Mkt cap ! $94.89M

Open	High	Low	Value	Volume
19.0¢	19.5¢	19.0¢	$58.40K	305.6K

Buyers (Bids)

No.	Vol.	Price($)
2	115000	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
19.5¢	86074	3

View Market Depth

No.	Vol.	Price($)
1	100000	0.190
8	156232	0.185
10	635662	0.180
10	482365	0.175
8	151233	0.170

Price($)	Vol.	No.
0.195	86074	3
0.200	256824	3
0.205	113150	5
0.210	333355	8
0.215	266995	7

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PAA (ASX) Chart

Paradigm Shift, page-22

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Paradigm Shift, page-22

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News